Home Newsfeeds CL King Initiates Coverage On Materion with Buy Rating, Announces Price Target of $95

CL King Initiates Coverage On Materion with Buy Rating, Announces Price Target of $95

CL King analyst David Silver initiates coverage on Materion (NYSE:MTRN) with a Buy rating and announces Price Target of $95.

byBenzinga Newsdesk

July 6, 2022

1 minute read

CL King analyst David Silver initiates coverage on Materion (NYSE:MTRN) with a Buy rating and announces Price Target of $95.

Credit Suisse Maintains Outperform on Hims & Hers Health, Raises Price Target to $14

By Benzinga Newsdesk

March 1, 9:52 AM

Credit Suisse analyst Jonathan Yong maintains Hims & Hers Health (NYSE:HIMS) with a Outperform and raises the price target from $8 to $14.

HIMS

Chinese-Owned Bitcoin Mine In Wyoming Raises National Security Concerns, US Officials Warn: NYT

By Benzinga Neuro

October 14, 4:42 AM

U.S. Pentagon officials are keeping close tabs on a Wyoming-based Bitcoin (CRYPTO: BTC) operation owned by Chinese interests amid fears of potential national security risks.

BTC

Movers
News

Sage Therapeutics Reports Phase 2 Huntington’s Data

By Dylan Berman

June 11, 11:52 AM

On Tuesday before the market opened, Sage Therapeutics announced findings regarding Huntington's Disease (HD) based upon topline results from the Phase 2 SURVEYOR Study.

SAGE

Why Cloud-Based Software Company Braze Shares Are Diving Today

By Lekha Gupta

March 28, 1:42 PM

Braze shares down after soft EPS guidance for Q1 and FY25. Yesterday, the company reported a fourth-quarter FY24 EPS loss of $(0.04), beating the $(0.05) estimate, and sales of $130.96 million exceeded the street view of $124.86 million.

BOUT

CL King Initiates Coverage On Materion with Buy Rating, Announces Price Target of $95

Related Posts

Credit Suisse Maintains Outperform on Hims & Hers Health, Raises Price Target to $14

Chinese-Owned Bitcoin Mine In Wyoming Raises National Security Concerns, US Officials Warn: NYT

Sage Therapeutics Reports Phase 2 Huntington’s Data

Why Cloud-Based Software Company Braze Shares Are Diving Today